The slightly weaker results are due to the specificities of the market situation during the period, the company said.
Sales revenues in H1 are up 3.43%, including a 17.96% in foreign currency terms.
Another factor limiting the company's sales is the continuing reconstruction of the ampule production department. In spite of that, Sopharma said the overall trend is positive.
12,034 shares traded hands today on BSE. The last deal was at 5.98%, which is 3.02% up from opening. The average for the at settled at 5.83 leva.